Jacobs Levy Equity Management
WINT icon

Jacobs Levy Equity Management’s Windtree Therapeutics Inc WINT Stock Holding History

Jacobs Levy Equity Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-51,102
Closed -$153K – 1227
2015
Q4 		$153K Buy
+51,102
New +$210K ﹤0.01% 717
2015
Q1 		– Sell
-4,271
Closed -$69K – 943
2014
Q4 		$69K Buy
+4,271
New +$93.9K ﹤0.01% 795

Other funds holding WINT

Broadfin Capital
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
DAFNA Capital Management
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management's WINT Position: Q1 2016 in Review

Jacobs Levy Equity Management sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 51,102 shares — an estimated $153K sold.

Jacobs Levy Equity Management first reported a position in WINT in Q4 2014 and held it in 2 quarters. The position peaked at $153K in Q4 2015. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

  • Jacobs Levy Equity Management reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 51,102 Windtree Therapeutics Inc shares in Q1 2016, an estimated $153K.
  • Jacobs Levy Equity Management first reported a position in Windtree Therapeutics Inc in Q4 2014 and held it in 2 quarters.
  • Jacobs Levy Equity Management's Windtree Therapeutics Inc position peaked at $153K in Q4 2015.
  • 34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2016, filed 16 May 2016.